1.1.................... moves to amend H.F. No. 1847 as follows:
1.2Delete everything after the enacting clause and insert:

1.3    "Section 1. [62A.3075] CANCER CHEMOTHERAPY TREATMENT
1.5(a) A health plan company that provides coverage under a health plan for cancer
1.6chemotherapy treatment shall not require a higher co-payment, deductible, or coinsurance
1.7amount for a prescribed, orally administered anticancer medication that is used to kill or
1.8slow the growth of cancerous cells than what the health plan requires for an intravenously
1.9administered or injected cancer medication that is provided, regardless of formulation or
1.10benefit category determination by the health plan company.
1.11(b) A health plan company shall not achieve compliance with this section
1.12by imposing an increase in co-payment, deductible, or coinsurance amount for an
1.13intravenously administered or injected cancer chemotherapy agents covered under the
1.14health plan.
1.15(c) Nothing in this section shall be interpreted to prohibit a health plan company
1.16from requiring prior authorization or imposing other appropriation utilization controls in
1.17approving coverage for any chemotherapy.
1.18EFFECTIVE DATE.Paragraphs (a) and (c) are effective August 1, 2010, and apply
1.19to health plans providing coverage to a Minnesota resident offered, issued, sold, renewed,
1.20or continued as defined in Minnesota Statutes, section 60A.02, subdivision 2a, on or after
1.21that date. Paragraph (b) is effective the day following final enactment."